Advertisement

European Archives of Oto-Rhino-Laryngology

, Volume 273, Issue 7, pp 1863–1869 | Cite as

Cartilage invasion patterns in laryngeal cancer

  • Manuel Gómez SerranoEmail author
  • María Cruz Iglesias Moreno
  • Jesús Gimeno Hernández
  • Luis Ortega Medina
  • Cristina Martín Villares
  • Joaquín Poch Broto
Head and Neck

Abstract

The cartilaginous invasion determines the T and is one of the most common sources of mistake in tumor staging. Also it is of great importance when planning any therapeutic alternative. In the latest revision of the TNM classification a clear distinction is made between infiltration of cartilage without going through it, considered a T3 recently and that would be a T4 according to the previous classification, and those going through the cartilage, classified as T4a. While this classification makes the difference in depth of infiltration, it does not emphasize the extent of invasion. This paper provides a detailed description of the laryngeal cartilage tumor infiltration by whole organ serial section in which the invasion is considered both horizontal (transcartilaginous) and vertical (extent of invasion) and establishing patterns of three-dimensional infiltration of the cartilage. This is a cross-sectional study of prevalence. 275 records of patients treated for laryngeal squamous cell carcinoma between 1995 and 2000 were reviewed. The pathological processing of laryngectomy surgical specimens was performed following the method of whole organ serial section described by G. F. Tucker. The following patterns of cartilaginous infiltration were defined: (1) transcartilaginous infiltration; (2a) partial focal infiltration of the cartilage: infiltration not going through the cartilage but occupying one third or less of its extent; (2b) partial extensive infiltration of the cartilage: infiltration occupying two thirds or more of its length and (3) no cartilage infiltration: tumor in contact with the cartilage (paraglottic space) but without affecting it. 161 patients met the inclusion criteria. The most frequent tumor location was supraglottic (58 cases) followed by glottic (47). 109 patients (67.7 %) were treated with total laryngectomy. Partial surgical techniques were performed in the remaining cases. TNM tumor staging was performed according to the results of pathological study (pTNM). 72.06 % (116) were classified as advanced laryngeal tumors (pT3 and pT4). 46 % of patients showed some extent of laryngeal cartilage infiltration (thyroid, cricoid, arytenoids, epiglottis). The cartilage most frequently infiltrated was the thyroid in 48 patients (29.8 %) and when it is affected, in most cases (66.7 %), the infiltration is transcartilaginous. The next most common pattern is partial focal infiltration (27 %). In the cricoid cartilage, the most common pattern of infiltration is focal partial infiltration (52.6 %). Of the 19 cases with infiltration of the cricoid, there are 12 cases with extra laryngeal invasion through a cricothyroid membrane perforation. The study of laryngeal cancer by laryngeal whole serial section has been proved to be very useful in offering a high precision pTNM staging and a detailed description of the infiltration of cartilage. We have seen that when the thyroid cartilage is infiltrated the tumor often passes through the cartilage. However, there are cases where the tumor is extremely aggressive, being very widespread in cartilage thickness without actually crossing it. The isolated infiltration of the cricoid cartilage is exceptional.

Keywords

Larynx cancer Cartilage invasion patterns Thyroid Cricoid 

References

  1. 1.
    Martín Villares C, Poch Broto J (1999) Vías de expansión del cáncer de laringe. Tesis Doctoral. Universidad Complutense, MadridGoogle Scholar
  2. 2.
    Poch Broto J (2001) Cáncer de Laringe: De Manuel García Y T. Billroth a Nuestros Días. Curso Académico. Instituto de España. Real Academia Nacional de Medicina, MadridGoogle Scholar
  3. 3.
    Kirchner JA (1984) Invasion of the framework by laryngeal cancer. Surgical and radiological implications. Acta Otolaryngol 97(5–6):392–397. http://www.ncbi.nlm.nih.gov/pubmed/6464696. Accessed 5 Feb 2015
  4. 4.
    Nakayama M, Brandenburg JH (1993) Clinical underestimation of laryngeal cancer. Predictive indicators. Arch Otolaryngol Head Neck Surg 119(9):950–957. http://www.ncbi.nlm.nih.gov/pubmed/8357595. Accessed 5 Feb 2015
  5. 5.
    Pillsbury HR, Kirchner JA (1979) Clinical vs histopathologic staging in laryngeal cancer. Arch Otolaryngol 105(3):157–159. http://www.ncbi.nlm.nih.gov/pubmed/420656. Accessed 5 Feb 2015
  6. 6.
    Pfister DG, Sa Laurie, Weinstein GS et al (2006) American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 24(22):3693–3704. doi: 10.1200/JCO.2006.07.4559 CrossRefPubMedGoogle Scholar
  7. 7.
    Fatterpekar GM, Mukherji SK, Rajgopalan P, Lin Y, Castillo M (2004) Normal age-related signal change in the laryngeal cartilages. Neuroradiology 46(8):678–681. doi: 10.1007/s00234-003-1153-3 CrossRefPubMedGoogle Scholar
  8. 8.
    Poch Broto J, Ortega Medina L, Martín Villares C (1996) Mecanismos de extensión. In: Farma C (ed) Cáncer de Laringe. Ponencia Official Del XVI Congreso de La SEORL, Madrid, pp 133–155Google Scholar
  9. 9.
    Bron LP, Soldati D, Monod M-L et al (2005) Horizontal partial laryngectomy for supraglottic squamous cell carcinoma. Eur Arch Otorhinolaryngol 262(4):302–306. doi: 10.1007/s00405-004-0824-y CrossRefPubMedGoogle Scholar
  10. 10.
    Castelijns JA, Becker M, Hermans R (1996) Impact of cartilage invasion on treatment and prognosis of laryngeal cancer. Eur Radiol 6(2):156–169. http://www.ncbi.nlm.nih.gov/pubmed/8797973. Accessed 5 Feb 2015
  11. 11.
    Murakami R, Nishimura R, Baba Y et al (2005) Prognostic factors of glottic carcinomas treated with radiation therapy: value of the adjacent sign on radiological examinations in the sixth edition of the UICC TNM staging system. Int J Radiat Oncol Biol Phys 61(2):471–475. doi: 10.1016/j.ijrobp.2004.05.024 CrossRefPubMedGoogle Scholar
  12. 12.
    Becker M (2000) Neoplastic invasion of laryngeal cartilage: radiologic diagnosis and therapeutic implications. Eur J Radiol 33(3):216–229. http://www.ncbi.nlm.nih.gov/pubmed/10699738. Accessed 5 Feb 2015
  13. 13.
    Forastiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349(22):2091–2098. doi: 10.1056/NEJMoa031317 CrossRefPubMedGoogle Scholar
  14. 14.
    Lefebvre JL, Rolland F, Tesselaar M et al (2009) Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst 101(3):142–152. doi: 10.1093/jnci/djn460 CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Lorch JH, Goloubeva O, Haddad RI et al (2011) Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. Lancet Oncol 12(2):153–159. doi: 10.1016/S1470-2045(10)70279-5 CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Pointreau Y, Garaud P, Chapet S et al (2009) Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 101(7):498–506. doi: 10.1093/jnci/djp007 CrossRefPubMedGoogle Scholar
  17. 17.
    Vermorken JB, Remenar E, van Herpen C et al (2007) Cisplatin, fluorouracil, and docetaxel in unrespectable head and neck cancer. N Engl J Med 357(17):1695–1704. doi: 10.1056/NEJMoa071028 CrossRefPubMedGoogle Scholar
  18. 18.
    Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471–1474. doi: 10.1245/s10434-010-0985-4 CrossRefPubMedGoogle Scholar
  19. 19.
    Tucker GF (1961) A histological method for the study of the spread of carcinoma within the larynx. Ann Otol Rhinol Laryngol 70:910–921. http://www.ncbi.nlm.nih.gov/pubmed/13922993. Accessed 6 Feb 2015
  20. 20.
    Barnes L, Johnson JT (1986) Pathologic and clinical considerations in the evaluation of major head and neck specimens resected for cancer part I. Pathol Annu 21 Pt 1:173–250. http://www.ncbi.nlm.nih.gov/pubmed/3510415. Accessed 6 Feb 2015
  21. 21.
    Kirchner JA (1975) Pyriform sinus cancer: a clinical and laboratory study. Ann Otol Rhinol Laryngol 84(6):793–803. http://www.ncbi.nlm.nih.gov/pubmed/1200569. Accessed 6 Feb 2015
  22. 22.
    Gallo A, Mocetti P, De Vincentiis M et al (1992) Neoplastic infiltration of laryngeal cartilages: histocytochemical study. Laryngoscope 102(8):891–895. doi: 10.1288/00005537-199208000-00008 CrossRefPubMedGoogle Scholar
  23. 23.
    Buckley JG, MacLennan K (2000) Cancer spread in the larynx: a pathologic basis for conservation surgery. Head Neck 22(3):265–274. http://www.ncbi.nlm.nih.gov/pubmed/10748450. Accessed 6 Feb 2015
  24. 24.
    Thoeny HC, Delaere PR, Hermans R (2005) Correlation of local outcome after partial laryngectomy with cartilage abnormalities on CT. AJNR Am J Neuroradiol 26(3):674–678PubMedGoogle Scholar
  25. 25.
    Sparano A, Chernock R, Feldman M, Laccourreye O, Brasnu D, Weinstein G (2005) Extending the inferior limits of supracricoid partial laryngectomy: a clinicopathological correlation. Laryngoscope 115(2):297–300. doi: 10.1097/01.mlg.0000154737.46528.82 CrossRefPubMedGoogle Scholar
  26. 26.
    Kirchner JA, Carter D (1987) Intralaryngeal barriers to the spread of cancer. Acta Otolaryngol 103(5–6):503–513. http://www.ncbi.nlm.nih.gov/pubmed/3618179. Accessed 6 Feb 2015
  27. 27.
    Fagan JJ, D’Amico F, Wagner RL, Johnson JT (1998) Implications of cartilage invasion in surgically treated laryngeal carcinoma. Head Neck 20(3):189–192. http://www.ncbi.nlm.nih.gov/pubmed/9570622. Accessed 5 Feb 2015
  28. 28.
    Yilmaz T, Hoşal AS, Gedikoğlu G, Kaya S (1999) Prognostic significance of histopathological parameters in cancer of the larynx. Eur Arch Otorhinolaryngol 256(3):139–144. http://www.ncbi.nlm.nih.gov/pubmed/10234483. Accessed 5 Feb 2015
  29. 29.
    Yeager VL, Archer CR (1982) Anatomical routes for cancer invasion of laryngeal cartilages. Laryngoscope 92(4):449–452. http://www.ncbi.nlm.nih.gov/pubmed/7070185. Accessed 6 Feb 2015
  30. 30.
    Dyess CL, Carter D, Kirchner JA, Baron RE (1987) A morphometric comparison of the changes in the laryngeal skeleton associated with invasion by tumor and by external-beam radiation. Cancer 59(6):1117–1122. http://www.ncbi.nlm.nih.gov/pubmed/3815286. Accessed 1 June 2015
  31. 31.
    Kirchner JA (1989) Fifteenth Daniel C. Baker Jr, memorial lecture. What have whole organ sections contributed to the treatment of laryngeal cancer? Ann Otol Rhinol Laryngol 98(9):661–667. http://www.ncbi.nlm.nih.gov/pubmed/2782798. Accessed 1 June 2015
  32. 32.
    Targa L, Grandi E, Chiarello G et al (2005) Prognostic evaluation in supracricoid partial laryngectomy with cricohyoidopexy. Eur Arch Otorhinolaryngol 262(6):465–469. doi: 10.1007/s00405-004-0856-3 CrossRefPubMedGoogle Scholar
  33. 33.
    Laccourreye O, Muscatello L, Laccourreye L, Naudo P, Brasnu D, Weinstein G (1997) Supracricoid partial laryngectomy with cricohyoidoepiglottopexy for “early” glottic carcinoma classified as T1–T2N0 invading the anterior commissure. Am J Otolaryngol 18(6):385–390. http://www.ncbi.nlm.nih.gov/pubmed/9395014. Accessed 1 June 2015
  34. 34.
    Bron LP, Soldati D, Zouhair A et al (2001) Treatment of early stage squamous-cell carcinoma of the glottic larynx: endoscopic surgery or cricohyoidoepiglottopexy versus radiotherapy. Head Neck 23(10):823–829. http://www.ncbi.nlm.nih.gov/pubmed/11592228. Accessed 1 June 2015
  35. 35.
    De Campora E, Radici M, Bicciolo G (1995) Laryngeal T4 carcinomas. The possibility of conservative treatment. Long-term oncological and functional results. Acta Otorhinolaryngol Ital 15(1):28–39. http://www.ncbi.nlm.nih.gov/pubmed/7597900. Accessed 1 June 2015
  36. 36.
    Norris CM, Kuo BF, Tucker GF, Pitser WF (1970) A correlation of clinical staging, pathological findings and five year end results in surgically treated cancer of the larynx. Ann Otol Rhinol Laryngol 79(6):1033–1048. http://www.ncbi.nlm.nih.gov/pubmed/5490189. Accessed 1 June 2015
  37. 37.
    Gregor RT, Hammond K (1987) Framework invasion by laryngeal carcinoma. Am J Surg 154(4):452–458. http://www.ncbi.nlm.nih.gov/pubmed/3116872. Accessed 1 June 2015
  38. 38.
    Murakami R, Furusawa M, Baba Y et al (2000) Dynamic helical CT of T1 and T2 glottic carcinomas: predictive value for local control with radiation therapy. AJNR Am J Neuroradiol 21(7):1320–1326. http://www.ncbi.nlm.nih.gov/pubmed/10954287. Accessed 1 June 2015
  39. 39.
    Pameijer FA, Mancuso AA, Mendenhall WM, Parsons JT, Kubilis PS (1997) Can pretreatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy? Int J Radiat Oncol Biol Phys 37(5):1011–1021. http://www.ncbi.nlm.nih.gov/pubmed/9169807. Accessed 1 June 2015
  40. 40.
    Hermans R, Van den Bogaert W, Rijnders A, Doornaert P, Baert AL (1999) Predicting the local outcome of glottic squamous cell carcinoma after definitive radiation therapy: value of computed tomography-determined tumour parameters. Radiother Oncol 50(1):39–46. http://www.ncbi.nlm.nih.gov/pubmed/10225556. Accessed 1 June 2015
  41. 41.
    Nguyen-Tan PF, Le QT, Quivey JM et al (2001) Treatment results and prognostic factors of advanced T3–4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience. Int J Radiat Oncol Biol Phys 50(5):1172–1180. http://www.ncbi.nlm.nih.gov/pubmed/11483326. Accessed 1 June 2015

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Manuel Gómez Serrano
    • 1
    Email author
  • María Cruz Iglesias Moreno
    • 1
  • Jesús Gimeno Hernández
    • 1
  • Luis Ortega Medina
    • 2
  • Cristina Martín Villares
    • 3
  • Joaquín Poch Broto
    • 1
  1. 1.Department of Otolaryngology and Head and Neck SurgeryHospital Clínico San CarlosMadridSpain
  2. 2.Department of PathologyHospital Clínico San CarlosMadridSpain
  3. 3.Department of Otolaryngology and Head and Neck SurgeryHospital de la ReinaPonferradaSpain

Personalised recommendations